Recycling of apolipoprotein E is not associated with cholesterol efflux in neuronal cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1781, Issue 5, 2008, Pages 232-238

  Rellin, Lars ^a   Heeren, Joerg ^a   Beisiegel, Ulrike ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cholesterol; Endocytosis; Lipoprotein

Indexed keywords

APOLIPOPROTEIN E;

ANIMAL CELL; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; CELL LINE; CHOLESTEROL, HDL; HEPATOCYTES; HUMANS; MICE; NEURONS; PROTEIN ISOFORMS;

MURINAE;

EID: 43149088247     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2008.02.001     Document Type: Article

References (47)

1. Gregg R.E., Zech L.A., Schaefer E.J., Stark D., Wilson D., and Brewer Jr. H.B. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J. Clin. Invest. 78 (1986) 815
2. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921
3. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., and Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342 (1993) 697
4. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., and Alberts M.J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467
5. Heeren J., Grewal T., Jackle S., and Beisiegel U. Recycling of apolipoprotein E and lipoprotein lipase through endosomal compartments in vivo. J. Biol. Chem. 276 (2001) 42333
6. Heeren J., Grewal T., Laatsch A., Rottke D., Rinninger F., Enrich C., and Beisiegel U. Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization. J. Biol. Chem. 278 (2003) 14370
7. Heeren J., Grewal T., Laatsch A., Becker N., Rinninger F., Rye K.A., and Beisiegel U. Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J. Biol. Chem. 279 (2004) 55483
8. Koldamova R.P., Lefterov I.M., Ikonomovic M.D., Skoko J., Lefterov P.I., Isanski B.A., DeKosky S.T., and Lazo J.S. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J. Biol. Chem. 278 (2003) 13244
9. Kim W.S., Rahmanto A.S., Kamili A., Rye K.A., Guillemin G.J., Gelissen I.C., Jessup W., Hill A.F., and Garner B. Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J. Biol. Chem. 282 (2007) 2851
10. Wang N., Yvan-Charvet L., Lutjohann D., Mulder M., Vanmierlo T., Kim T.W., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain. FASEB J. (2007) (Electronic publication ahead of print)
11. Chroni A., Nieland T.J., Kypreos K.E., Krieger M., and Zannis V.I. SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. Biochemistry 44 (2005) 13132
12. Koch S., Donarski N., Goetze K., Kreckel M., Stuerenburg H.J., Buhmann C., and Beisiegel U. Characterization of four lipoprotein classes in human cerebrospinal fluid. J. Lipid Res. 42 (2001) 1143
13. LaDu M.J., Reardon C., Van Eldik L., Fagan A.M., Bu G., Holtzman D., and Getz G.S. Lipoproteins in the central nervous system. Ann. N.Y. Acad. Sci. 903 (2000) 167
14. Boyles J.K., Zoellner C.D., Anderson L.J., Kosik L.M., Pitas R.E., Weisgraber K.H., Hui D.Y., Mahley R.W., Gebicke-Haerter P.J., and Ignatius M.J. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest 83 (1989) 1015
15. DeMattos R.B., Rudel L.L., and Williams D.L. Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth. J. Lipid Res. 42 (2001) 976
16. Gong J.S., Kobayashi M., Hayashi H., Zou K., Sawamura N., Fujita S.C., Yanagisawa K., and Michikawa M. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J. Biol. Chem. 277 (2002) 29919
17. Edmond J., Korsak R.A., Morrow J.W., Torok-Both G., and Catlin D.H. Dietary cholesterol and the origin of cholesterol in the brain of developing rats. J. Nutr. 121 (1991) 1323
18. Jurevics H., and Morell P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64 (1995) 895
19. Bjorkhem I., and Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 806
20. Saito M., Benson E.P., Saito M., and Rosenberg A. Metabolism of cholesterol and triacylglycerol in cultured chick neuronal cells, glial cells, and fibroblasts: accumulation of esterified cholesterol in serum-free culture. J. Neurosci. Res. 18 (1987) 319
21. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., and Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76 (1985) 1501
22. DeMattos R.B., Brendza R.P., Heuser J.E., Kierson M., Cirrito J.R., Fryer J., Sullivan P.M., Fagan A.M., Han X., and Holtzman D.M. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem. Int. 39 (2001) 415
23. Fagan A.M., Bu G., Sun Y., Daugherty A., and Holtzman D.M. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271 (1996) 30121
24. Pitas R.E., Boyles J.K., Lee S.H., Hui D., and Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem. 262 (1987) 14352
25. Quan G., Xie C., Dietschy J.M., and Turley S.D. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res. Dev. Brain Res. 146 (2003) 87
26. Nunan J., and Small D.H. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483 (2000) 6
27. Cam J.A., and Bu G. Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family. Mol. Neurodegener. 1 (2006) 8
28. Vetrivel K.S., and Thinakaran G. Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments. Neurology 66 (2006) S69-S73
29. Bodovitz S., and Klein W.L. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271 (1996) 4436
30. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., and Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6460
31. Wahrle S., Das P., Nyborg A.C., McLendon C., Shoji M., Kawarabayashi T., Younkin L.H., Younkin S.G., and Golde T.E. Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9 (2002) 11
32. Maher P., and Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16 (1996) 6394
33. Wente W., Efanov A.M., Brenner M., Kharitonenkov A., Koster A., Sandusky G.E., Sewing S., Treinies I., Zitzer H., and Gromada J. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55 (2006) 2470
34. Heeren J., Weber W., and Beisiegel U. Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. J. Cell Sci. 112 Pt 3 (1999) 349
35. Holtzman D.M., Pitas R.E., Kilbridge J., Nathan B., Mahley R.W., Bu G., and Schwartz A.L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9480
36. Hirsch-Reinshagen V., Zhou S., Burgess B.L., Bernier L., McIsaac S.A., Chan J.Y., Tansley G.H., Cohn J.S., Hayden M.R., and Wellington C.L. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem. 279 (2004) 41197
37. Morimoto B.H., and Koshland Jr. D.E. Excitatory amino acid uptake and N-methyl-d-aspartate-mediated secretion in a neural cell line. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3518
38. Herz J., and Bock H.H. Lipoprotein receptors in the nervous system. Annu. Rev. Biochem. 71 (2002) 405
39. Ruiz J., Kouiavskaia D., Migliorini M., Robinson S., Saenko E.L., Gorlatova N., Li D., Lawrence D., Hyman B.T., Weisgraber K.H., and Strickland D.K. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J. Lipid Res. 46 (2005) 1721
40. Chou C.Y., Jen W.P., Hsieh Y.H., Shiao M.S., and Chang G.G. Structural and functional variations in human apolipoprotein e3 and e4. J. Biol. Chem. 281 (2006) 13333
41. Sekiguchi R.T., Potter-Perigo S., Braun K., Miller J., Ngo C., Fukuchi K., Wight T.N., Kimata K., and Snow A.D. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation. J. Neurosci. Res. 38 (1994) 670
42. Dekroon R.M., and Armati P.J. The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes. Neurobiol. Dis. 8 (2001) 78
43. Ji Z.S., Pitas R.E., and Mahley R.W. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4. J. Biol. Chem. 273 (1998) 13452
44. Hasty A.H., Plummer M.R., Weisgraber K.H., Linton M.F., Fazio S., and Swift L.L. The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I. J. Lipid Res. 46 (2005) 1433
45. Michikawa M., Fan Q.W., Isobe I., and Yanagisawa K. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J. Neurochem. 74 (2000) 1008
46. Gong J.S., Morita S.Y., Kobayashi M., Handa T., Fujita S.C., Yanagisawa K., and Michikawa M. Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons. Mol. Neurodegener. 2 (2007) 9
47. Ye S., Huang Y., Mullendorff K., Dong L., Giedt G., Meng E.C., Cohen F.E., Kuntz I.D., Weisgraber K.H., and Mahley R.W. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18700